Singapore should not Invest in Research and Development (R&D) of In Vitro Gametogenesis (IVG) Technology for Human Clinical Assisted Reproduction
Singapore’s highly restrictive laws governing assisted reproduction—specifically the ban on surrogacy, the exclusion of same-sex couples from accessing fertility treatments, and strict limits on the number of donor offspring—will severely stifle any return on investment in IVG technology.